Docebo Inc (FRA:061)
€ 20.2 +1 (+5.21%) Market Cap: 512.29 Mil Enterprise Value: 553.87 Mil PE Ratio: 20.43 PB Ratio: 0 GF Score: 62/100

Q2 2026 Docebo Inc Earnings Call Transcript

Aug 7, 2026 / 12:00 PM GMT
Release Date Price: €19.2 (+9.71%)

Key Points

Positve
  • Docebo Inc (DCBO) reported a second consecutive quarter of ARR re-acceleration, driven by broad-based strength across net new, expansion, and international segments.
  • The company is seeing strong enterprise pipeline growth, with roughly 80% of enterprise deals involving partners, including key relationships with Deloitte and NIIT.
  • The integration of 365 Talents is ahead of schedule, contributing to significant wins like the world's largest telecom and automotive safety suppliers, and expanding the company's competitive positioning.
  • Docebo Inc (DCBO) is strategically entering the healthcare vertical, a $3 billion TAM, leveraging its existing $10 million ARR base and expecting to improve win rates within months, not years.
  • The upcoming launch of Agent Hub and Enterprise Knowledge in the fall is expected to drive new monetization opportunities and enhance the company's AI capabilities.
  • Management raised full-year revenue guidance by $3.5 million, reflecting increased confidence in enterprise segment performance and a strong FedRAMP pipeline for Q3.
Negative
  • Docebo Inc (DCBO) is investing in a new forward-deployed engineer (FDE) model, which will initially add R&D costs before any revenue contribution, potentially pressuring near-term margins.
  • The company's capital allocation is currently focused on share buybacks due to perceived undervaluation, but it carries $90 million in debt, and the upcoming SIB could increase net debt to $150 million.
  • Management remains cautious about providing detailed monetization plans for the FDE model and Agent Hub, indicating uncertainty about future revenue streams.
  • The healthcare vertical expansion is still in early stages, requiring significant investment in team and product development, with no immediate financial returns expected.
  • While sales cycles are not elongating, the company acknowledges that the re-acceleration is partly due to lapping easier comparisons from the AWS and Dayforce headwinds, which may not be sustainable.
  • The company's EBITDA guidance remains unchanged despite higher revenue, as investments in healthcare and R&D are expected to offset any margin improvements.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

DCBO.TO - Docebo Inc.
Q2 2026 Docebo Inc Earnings Call
Aug 07, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, everyone, and welcome to the Dusty Boat's second quarter 2026 earnings call. All participants are currently in a listen-only mode. We will open the line for a question-and-answer session momentarily. Analysts can ask questions by pressing star 1 on their telephone keypad. And if you would like to withdraw your question, again press star 1. We ask that analysts please limit themselves to two questions and return to the queue for any.

I'd now like to turn the call over to Dusty Bowles, Vice President of Investor Relations, Mike McCarthy. Please go ahead, Mike.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot